MedInvest, a leading healthcare, biotech, and medtech media and conference company, will host its semi-annual Biotech and Pharma Investor Conference in New York City on September 15-16, 2026.  The National Institutes of Health, National Cancer Institute, Citizens Bank and Hogan Lovells Cadwalader Law Firm will be presenting partners of the event.

 

The conference is expected to attract 100+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.

 

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.

​​

Speakers include, among others:

​Dr. Mikael Dolsten, Former President of Research, Pfizer | Former President of R&D, Wyeth | Former Worldwide Head of Research, Boehringer Ingelheim

Dr. Stelios Papadopoulos, Former Vice Chairman of Cowen

Greg Simon, Former President of the Biden Cancer Initiative | Former Executive Director of the White House Cancer Moonshot Taskforce | Former Senior VP Worldwide Policy and Patient Engagement at Pfizer

Dr. Alfred Slanetz, Chairman of the National Foundation for Cancer Research | Former CEO, Bluebird Bio | Former Head of Product Development, Genetech

Dr. Christiana Bardon, Managing Partner, MPM BioImpact

Philip Sawyer, Managing Partner, Bering Capital

Kaushik Srinivasan, Founder and Managing Partner, Cerulean Health

Steven Abernathy, Founder and Chairman, The Abernathy Group Family Office

Greg Grinberg, CEO, Origin Foundation

Michael Ross, Managing Partner, Joseph Ventures FO

Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), National Cancer Institute

Kristin Gerber, Partner, Hogan Lovells Cadwalader

Blake Wilson, Partner, Hogan Lovells Cadwalader​

​

​REGISTER HERE